Literature DB >> 26319528

Negative symptoms and therapy strategies in schizophrenia.

Andrea Schmitt1, Peter Falkai2.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 26319528     DOI： 10.1007/s00406-015-0637-6

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN： 0940-1334            Impact factor:   5.270


× No keyword cloud information.
  8 in total

Review 1.  Psychometric evaluation of the negative syndrome of schizophrenia.

Authors:  Maria Paz Garcia-Portilla; Leticia Garcia-Alvarez; Pilar A Saiz; Susana Al-Halabi; Maria Teresa Bobes-Bascaran; Maria Teresa Bascaran; José Muñiz; Julio Bobes
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2015-03-24       Impact factor: 5.270

2.  The impact of emotional faces on social motivation in schizophrenia.

Authors:  Sina Radke; Vera Pfersmann; Birgit Derntl
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2015-02-28       Impact factor: 5.270

Review 3.  Pharmacological treatment of negative symptoms in schizophrenia.

Authors:  Hans-Jürgen Möller; Pal Czobor
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2015-04-21       Impact factor: 5.270

Review 4.  Neurobiological background of negative symptoms.

Authors:  Silvana Galderisi; Eleonora Merlotti; Armida Mucci
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2015-03-24       Impact factor: 5.270

5.  Influence of empathetic pain processing on cognition in schizophrenia.

Authors:  Kesong Hu; Marijn Lijffijt; Theodore P Beauchaine; Zhiwei Fan; Hui Shi; Shuchang He
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2014-12-05       Impact factor: 5.270

6.  Antagonist and partial agonist at the dopamine D2 receptors in drug-naïve and non-drug-naïve schizophrenia: a randomized, controlled trial.

Authors:  Yoshiteru Takekita; Chiara Fabbri; Masaki Kato; Shinpei Nonen; Shiho Sakai; Naotaka Sunada; Yosuke Koshikawa; Masataka Wakeno; Gaku Okugawa; Toshihiko Kinoshita; Alessandro Serretti
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2015-05-28       Impact factor: 5.270

7.  Transcutaneous noninvasive vagus nerve stimulation (tVNS) in the treatment of schizophrenia: a bicentric randomized controlled pilot study.

Authors:  Alkomiet Hasan; Claus Wolff-Menzler; Sebastian Pfeiffer; Peter Falkai; Elif Weidinger; Andrea Jobst; Imke Hoell; Berend Malchow; Peyman Yeganeh-Doost; Wolfgang Strube; Silke Quast; Norbert Müller; Thomas Wobrock
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2015-07-26       Impact factor: 5.270

8.  Proteomics of the corpus callosum unravel pivotal players in the dysfunction of cell signaling, structure, and myelination in schizophrenia brains.

Authors:  Verônica M Saia-Cereda; Juliana S Cassoli; Andrea Schmitt; Peter Falkai; Juliana M Nascimento; Daniel Martins-de-Souza
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2015-08-01       Impact factor: 5.270
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.